References
Kendler KS, Karkowski LM et al. (1999)Genetic and environmental risk factors in the aetiology of illicit drug initiation and subsequent misuse in women. Br J Psychiatry 175:351–356
McBride WJ, Murphy JM, Ikemoto S (1999) Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101:129–152
Schuckit MA (2001) Correlates of unpredicted outcomes in sons of alcoholics and controls. J Stud Alcohol 62:477–485
Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine: a review. Pharmacol Rev 54:1–42
Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci 25:125–136
Tsuang MT, Lyons MJ et al. (1999) Genetic and environmental influences on transitions in drug use. Behav Genet 29:473–479
Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613–672
Uhl GR (1999) Molecular genetics of substance abuse vulnerability: a current approach. Neuropsychopharmacology 20:3–9
Uhl GR, Elmer GI et al. (1995) Genetic influences on drug abuse. In: Bloom F, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1793–1806
Uhl GR, Liu QR et al. (2002) Substance abuse vulnerability loci: converging genome scanning data. Trends Genet 18:420–425
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uhl, G.R. Needed: mouse/human cross validation of reinstatement/relapse models (and drug reward models) to model human substance abuse vulnerability allelic variants. Psychopharmacology 168, 42–43 (2003). https://doi.org/10.1007/s00213-003-1499-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1499-6